-
1
-
-
80755128213
-
Clinical diagnosis and management of amyotrophic lateral sclerosis
-
Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:639-649.
-
(2011)
Nat Rev Neurol
, vol.7
, pp. 639-649
-
-
Hardiman, O.1
van den Berg, L.H.2
Kiernan, M.C.3
-
2
-
-
84893649256
-
State of play in amyotrophic lateral sclerosis genetics
-
Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014;17:17-23.
-
(2014)
Nat Neurosci
, vol.17
, pp. 17-23
-
-
Renton, A.E.1
Chiò, A.2
Traynor, B.J.3
-
3
-
-
80755163102
-
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
-
Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:616-630.
-
(2011)
Nat Rev Neurol
, vol.7
, pp. 616-630
-
-
Ferraiuolo, L.1
Kirby, J.2
Grierson, A.J.3
Sendtner, M.4
Shaw, P.J.5
-
4
-
-
66749154197
-
Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis
-
Foran E, Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 2009;11:1587-1602.
-
(2009)
Antioxid Redox Signal
, vol.11
, pp. 1587-1602
-
-
Foran, E.1
Trotti, D.2
-
5
-
-
1842471942
-
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study
-
Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004;15:601-609.
-
(2004)
Neurobiol Dis
, vol.15
, pp. 601-609
-
-
Turner, M.R.1
Cagnin, A.2
Turkheimer, F.E.3
-
6
-
-
0027401203
-
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
-
Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
-
(1993)
Nature
, vol.362
, pp. 59-62
-
-
Rosen, D.R.1
Siddique, T.2
Patterson, D.3
-
7
-
-
77957317483
-
The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation
-
Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010;7:420-429.
-
(2010)
RNA Biol
, vol.7
, pp. 420-429
-
-
Buratti, E.1
Baralle, F.E.2
-
8
-
-
77953890823
-
TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration
-
Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: Emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 2010;19:R46-R64.
-
(2010)
Hum Mol Genet
, vol.19
-
-
Lagier-Tourenne, C.1
Polymenidou, M.2
Cleveland, D.W.3
-
9
-
-
84881024167
-
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
-
Cruts M, Gijselinck I, Van Langenhove T, van der Zee J, Van Broeckhoven C. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci 2013;36:450-459.
-
(2013)
Trends Neurosci
, vol.36
, pp. 450-459
-
-
Cruts, M.1
Gijselinck, I.2
Van Langenhove, T.3
van der Zee, J.4
Van Broeckhoven, C.5
-
10
-
-
84887233527
-
The epidemiology of ALS: A conspiracy of genes, environment and time
-
Al-Chalabi A, Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat Rev Neurol 2013;9:617-628.
-
(2013)
Nat Rev Neurol
, vol.9
, pp. 617-628
-
-
Al-Chalabi, A.1
Hardiman, O.2
-
11
-
-
80051972482
-
Emerging drugs for amyotrophic lateral sclerosis
-
Habib AA, Mitsumoto H. Emerging drugs for amyotrophic lateral sclerosis. Expert Opin Emerg Drugs 2011;16:537-558.
-
(2011)
Expert Opin Emerg Drugs
, vol.16
, pp. 537-558
-
-
Habib, A.A.1
Mitsumoto, H.2
-
12
-
-
52949103699
-
The endocannabinoid system in amyotrophic lateral sclerosis
-
Bilsland LG, Greensmith L. The endocannabinoid system in amyotrophic lateral sclerosis. Curr Pharm Des 2008;14:2306-2316.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 2306-2316
-
-
Bilsland, L.G.1
Greensmith, L.2
-
13
-
-
2442484678
-
Amyotrophic lateral sclerosis: Delayed disease progression in mice by treatment with a cannabinoid
-
Raman C, McAllister SD, Rizvi G, et al. Amyotrophic lateral sclerosis: Delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:33-39.
-
(2004)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.5
, pp. 33-39
-
-
Raman, C.1
McAllister, S.D.2
Rizvi, G.3
-
14
-
-
26444608731
-
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival
-
Weydt P, Hong S, Witting A, et al. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotroph Lateral Scler Other Motor Neuron Disord 2005;6:182-184.
-
(2005)
Amyotroph Lateral Scler Other Motor Neuron Disord
, vol.6
, pp. 182-184
-
-
Weydt, P.1
Hong, S.2
Witting, A.3
-
15
-
-
33845683331
-
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
-
Bilsland LG, Dick JR, Pryce G, et al. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J 2006;20:1003-1005.
-
(2006)
FASEB J
, vol.20
, pp. 1003-1005
-
-
Bilsland, L.G.1
Dick, J.R.2
Pryce, G.3
-
16
-
-
33746261289
-
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
-
Kim K, Moore DH, Makriyannis A, Abood ME. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur J Pharmacol 2006;542:100-105.
-
(2006)
Eur J Pharmacol
, vol.542
, pp. 100-105
-
-
Kim, K.1
Moore, D.H.2
Makriyannis, A.3
Abood, M.E.4
-
17
-
-
33947278309
-
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
-
Shoemaker JL, Seely KA, Reed RL, et al. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J Neurochem 2007;101:87-98.
-
(2007)
J Neurochem
, vol.101
, pp. 87-98
-
-
Shoemaker, J.L.1
Seely, K.A.2
Reed, R.L.3
-
18
-
-
33645224970
-
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
-
Yiangou Y, Facer P, Durrenberger P, et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 2006;6:12.
-
(2006)
BMC Neurol
, vol.6
, pp. 12
-
-
Yiangou, Y.1
Facer, P.2
Durrenberger, P.3
-
19
-
-
33845959991
-
Cannabinoid CB2 receptor: A new target for controlling neural cell survival?
-
Fernández-Ruiz J, Romero J, Velasco G, et al. Cannabinoid CB2 receptor: A new target for controlling neural cell survival? Trends Pharmacol Sci 2007;28:39-45.
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 39-45
-
-
Fernández-Ruiz, J.1
Romero, J.2
Velasco, G.3
-
20
-
-
34347397535
-
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
-
Ashton JC, Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 2007;5:73-80.
-
(2007)
Curr Neuropharmacol
, vol.5
, pp. 73-80
-
-
Ashton, J.C.1
Glass, M.2
-
21
-
-
3042559925
-
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice
-
Witting A, Weydt P, Hong S, et al. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. J Neurochem 2004;89:1555-1557.
-
(2004)
J Neurochem
, vol.89
, pp. 1555-1557
-
-
Witting, A.1
Weydt, P.2
Hong, S.3
-
23
-
-
84868128338
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities
-
Pertwee RG. Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 2012;367:3353-3363.
-
(2012)
Philos Trans R Soc Lond B Biol Sci
, vol.367
, pp. 3353-3363
-
-
Pertwee, R.G.1
-
24
-
-
80051830113
-
Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS)
-
Mead RJ, Bennett EJ, Kennerley AJ, et al. Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS). PLoS ONE 2011;6:e23244.
-
(2011)
PLoS ONE
, vol.6
-
-
Mead, R.J.1
Bennett, E.J.2
Kennerley, A.J.3
-
25
-
-
84872256489
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
-
Fernández-Ruiz J, Sagredo O, Pazos MR, et al. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? Br J Clin Pharmacol 2013;75:323-333.
-
(2013)
Br J Clin Pharmacol
, vol.75
, pp. 323-333
-
-
Fernández-Ruiz, J.1
Sagredo, O.2
Pazos, M.R.3
-
26
-
-
84892749496
-
Pregnenolone can protect the brain from cannabis intoxication
-
Vallée M, Vitiello S, Bellocchio L, et al. Pregnenolone can protect the brain from cannabis intoxication. Science 2014;343:94-98.
-
(2014)
Science
, vol.343
, pp. 94-98
-
-
Vallée, M.1
Vitiello, S.2
Bellocchio, L.3
-
27
-
-
84883894167
-
Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats
-
Caruso D, Pesaresi M, Abbiati F, et al. Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain, spinal cord and peripheral nerve levels in male and female rats. Psychoneuroendocrinology 2013;38:2278-2290.
-
(2013)
Psychoneuroendocrinology
, vol.38
, pp. 2278-2290
-
-
Caruso, D.1
Pesaresi, M.2
Abbiati, F.3
-
28
-
-
38349158960
-
9-tetrahydrocannabivarin
-
9-tetrahydrocannabivarin. Br J Pharmacol 2008;153:199-215.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 199-215
-
-
Pertwee, R.G.1
|